A respirable composition for treatment of a bacterial infection includes one or more active bacteriophages in combination with a pharmaceutically acceptable respirable carrier. The composition includes a carbohydrate carrier, and is prepared as fine powder. In another aspect, bacteriophages are provided in a liquid carrier for administration by nebulization. In one aspect, the bacteriophages have anti-bacterial activity against one or more species or strains of Burkholderia cepacia complex (BCC) bacteria. The invention further relates to the use of a BCC bacteriophage to treat a BCC infection, in particular in an individual suffering from cystic fibrosis.

Finlay; Warren H.

Dennis; Jonathan J.

Orszanska; Helena

cystic fibrosis/carbohydrate

Bacteriophage compositions for treatment of bacterial infections

Najkompletnija baza ljekovitog bilja potpomognuta znanošću